Bovine herpesvirus type 4 proteins were identified by PAGE of [35S]methionine-or [3H]glucosamine-labelled purified virions. Thirty-one monoclonal antibodies (MAbs) raised against the V.Test strain were used to identify 29 proteins, ten of which were glycosylated. All of these glycoproteins belonged to the viral envelope and a 140K nonglycosylated protein appeared to be the major nucleocapsid protein. The MAbs were classifiedinto two groups. The first group precipitated three glycoproteins of Mr 150K, 120K and 51K. The 120K and 51K glycoproteins were linked by disulphide bonds and the 150K glycoprotein was linked to the others by non-covalent bonds. The second group precipitated a different 120K glycoprotein.
INTRODUCTION
Bovine herpesvirus type 4 (BHV-4) is different from the well known BHV-1 and BHV-2 responsible for infectious bovine rhinotracheitis and bovine herpes mammillitis respectively. On the basis of some of its biological characteristics, such as its morphogenesis and slow growth, BHV-4 was tentatively classified as a cytomegalovirus (Storz et al., 1984) . Recent data on its genome have prompted Kit et al. (1986) to classify the virus in the group B herpesviruses, and it should therefore be more closely related to the Gammaherpesvirinae. Indeed, the BHV-4 genome contains polyrepetitive DNA segments at both genome termini in the same orientation as in herpesvirus saimiri (Ehlers et al., 1985) .
BHV-4 strains have been isolated from cows with various clinical conditions (ocular or respiratory diseases, genital diseases, skin lesions, malignant catarrhal fever and enteric diseases) as well as from healthy cattle (reviewed by Thiry et al., 1989) . These isolates were classified as BHV-4 according to their serological, biological and genetic similarities (Dubuisson et al., 1988) . Several strains of BHV-4 have been isolated in America and in Europe. Moreover the African strains isolated from skin lesions or 'epivag' syndrome (Theodoridis, 1978) probably belong to this bovine herpesvirus group. Experimental infections with BHV-4 indicate that few isolates appear to be pathogenic and most of them induce only mild clinical signs in experimentally infected cattle (reviewed by Thiry et al., 1989) . Nevertheless in cattle, BHV-4 has been frequently associated with genital disorders (Castrucci et al., 1986) and its role in the aetiology of some diseases of the genital tract is suggested further by recent work (Wellemans et al., 1986) .
Various roles have been attributed to glycoproteins of herpes simplex virus (HSV): they mediate viral attachment to host cell, penetration of the virion into the cell, they induce the production of neutralizing antibodies and determine the interactions between the host immune system and the virus-infected cells, as well as between infected cells themselves (reviewed by Spear, 1985) . Earlier studies on the morphology of BHV-4 have shown that the structure of this virus is that of a typical herpesvirus (Todd & Storz, 1983) , but the structural components of 0000-8854 © 1989 SGM BHV-4 have not been characterized. In this paper, we report on the identification of BHV-4 structural proteins and more specifically of BHV-4 glycoproteins.
METHODS
Cells and virus. The BHV-4 strain used in this work was the V.Test strain isolated from a case of orchitis (Thiry et al., 1981) . Georgia bovine kidney (GBK) cells were cultured in MEM as previously described (Dubuisson et al., 1987) for BHV-4 multiplication. Each virus used in these experiments was plaque-purified.
Preparation of purified labelled virus. GBK cells grown to confluence were infected at a multiplicity of 10 p.f.u./cell and incubated for 4 h at 37 °C in MEM with 2~ foetal calf sernm. Infected cells were washed twice with methionine-free MEM and incubated with the latter containing 2~ foetal calf serum. Eight h after infection, 25 ~tCi/ml of [3sS]methionine (1255 Ci/mmol; Amersham) was added. Three days later, when the c.p.e, involved less than 30~ of the cell sheet, the virus was harvested and purified from supernatant fluid by differential centrifugation through a cushion of 30~ sucrose in phosphate-buffered saline [PBS: 3 mM-KCI, 1.5 mM-KH2PO4, 0"14 M-NaC1, 6-5 mM-Na2HPO,(2H20), pH 7.2] and rate-zonal centrifugation through a potassium tartrate gradient (20 to 509/o potassium tartrate in PBS, pH 7.2) as described by Misra et al. (1981) .
The labelling of glycoproteins was achieved by the addition of 50 ~tCi/ml of [3H]glucosamine (39 Ci/mmol; Amersham) to the infected culture 8 h after infection.
Removal ofvirion envelope. The virion envelope was removed as described by Hampl et al. (1984) . Briefly, Triton X-100 (final concentration 1 ~) was added to purified virions (in PBS). After 20 min incubation at 45 °C, virus particles were spun for 1 h in an Eppendorf centrifuge. The supernatant (envelope fraction) was collected and the pellet (nucleocapsid fraction) was washed once with PBS.
SDS-PAGE. This was performed on slab gels according to the procedure of Laemmli (1970) . Resolving gels of 7.5, 10 and 15~ were used routinely. After electrophoresis, gels were treated with En3Hance (New England Nuclear), dried, and exposed to Kodak XAR-5 films. The Mr values of radioactive bands were determined by running, in parallel, 1*C-labelled Mr standards (Bethesda Research Laboratories).
Monoclonal antibodies (MAbs) to BHV-4. Production of MAbs to BHV-4 has been described . Thirty-one cell lines producing MAbs to BHV-4 were used. Ascites fluids obtained from BALB/c mice bearing intraperitoneal hybridomas were harvested, filtered on Whatman 2v filter and stored at -20°C. Purification of IgG fractions of MAbs was carried out according to Ey et al. (1978) as modified by Sepp~il~i et al. (1981) , using Protein A Sepharose CL-4B (Pharmacia).
ELISA. The ELISA was performed according to van Drunen Little-van den Hurk et al. (1984) except that MAbs used in this work were purified and the substrate solution was composed of 0.4 mg/ml of o-phenylenediamine and 0.01 ~ H202 in citrate buffer (0-1 M, pH 5). The avidities of MAbs were estimated using the absorbance value (A492) of the ELISA at the plateau level as described by Bruck et al. (1982) and van Drunen Little-van den Hurk et al. (1985) .
Preparation of antigen for immunoprecipitation. Antigen used in this work was prepared as described by van Drunen Little-van den Hurk et al. (1984) . Briefly, two sources of antigen were used: [35S]methionine-labelled purified virus prepared as above, and [35S]methionine-or [3H]glucosamine-labelled BHV-4-infected cell culture (harvested at 40 h) in radioimmunoprecipitation assay (RIPA) buffer (0.15 M-NaC1, 0'05 M-Tris-HCI pH 7-2, 1% Triton X-100, 0.1 ~ SDS, 1 ~ sodium deoxycholate, 0-1 ~ NAN3).
Immunoprecipitation. Sixty ~tl of a 10 ~ Protein A-Sepharose CL-4B (Pharmacia) suspension in phosphate buffer (0.1 M, pH 8.1) was incubated for 30 min with 20 ~tl of rabbit anti-mouse immunoglobulins (Dakopatts). After washing twice with phosphate buffer, 100 ~tl of 10-fold concentrated hybridoma culture supernatant was added for 1 h. The Sepharose beads were washed twice and 100 ~tl antigen was added overnight at 4 °C. Immunobeads were then washed four times with RIPA buffer and resuspended in 50 ~tl of the sample buffer used for SDS-PAGE, containing 2-mercaptoethanol for reducing conditions, or without for non-reducing conditions. In order to dissociate the immune complexes, the samples were boiled for 5 min prior to electrophoresis. Immunoprecipitation with bovine serum was performed following the same procedure except that rabbit anti-mouse immunoglobulins were replaced by rabbit anti-bovine immunoglobulins. Bovine sera were collected from experimentally infected bulls at day 30 post-infection.
Western blotting. BHV-4 used for Western blotting was purified from the supernatant of infected GBK cell cultures by differential centrifugation through a cushion of 30 ~ sucrose and resuspended in PBS. SDS-PAGE was performed as previously described; Western blotting was performed according to Herring & Sharp (1984) .
RESULTS

BHV-4 structural proWins
In the potassium tartrate gradients the radiolabelled BHV-4 was resolved into a single peak and no accessory peak was detected when the cells were infected at an m.o.i, of 10 p.f.u./cell. [35S]Methionine-and [3H]glucosamine-labelled BHV-4 was recovered from the radioactive peak and analysed by SDS-PAGE, followed by autoradiography. S D S -P A G E and immunoprecipitation by MAbs revealed 29 bands ( Fig. 1 ; Table 1 ). The Mr values of these bands ranged from over 300K down to 11K. A total of 10 of these bands (GVP3, GVP6, GVP8, GVP10, G V P l l , GVP16, GVP17, GVP18, GVP21 and GVP29) were glycosylated ( Fig. 2 ; Table 1 ).
From 10 glycoproteins identified after [3H]glucosamine labelling, only six were precipitated by sera from infected cattle (GVP3, GVP6, GVP8, GVP10, G V P l l and GVP17). Table 1 shows the relative intensity of the bands after [3SS]methionine labelling. VP7 (140K) was present in a relatively large amount and this was confirmed by staining with Coomassie Brilliant Blue (data not shown). Three bands (GVP21, VP27 and GVP29) were visible only after [3H]glucosamine labelling or immunoprecipitations. GPV6, GVPS, GVP10 and G V P l l were relatively highly glycosylated (Fig. 2) . All the glycoproteins appeared to be specifically solubilized by treatment of the virions with Triton X-100. Sometimes another band was apparent in the envelope fraction only and was probably a cellular contaminant or a degraded product ( Fig. 1 ; lane 3, star). Three non-glycosylated proteins (VP5, VP27 and VP28) were solubilized by treatment with Triton X-100. Three other non-glycosylated proteins (VP19, VP24 and VP26) were distributed in the envelope and nucleocapsid fractions.
Avidity of the MAbs
In order to evaluate their relative avidities, the MAbs were compared with respect to their activity in antibody binding assays. This was achieved in parallel titrations by indirect ELISA of each of the MAbs, using a single BHV-4 preparation as antigen. The relative avidities were classifiedaslow(A492 < 0.75), intermediate(0.75 < A492 < 1.00)andhigh(A~92 > 1-00)(Table2).
Immunoreactivity of BHV-4 proteins with MAbs
MAbs used in this work were arranged into two groups on the basis of their antigenic specifcity. The first group (group 1) contained 17 MAbs (VT-1, VT-8, VT-10, VT-12, VT-15, * Proteins present in the envelope fraction after treatment of purified virus with Triton X-100 (Fig. 1) . t Proteins present in the nucleocapsid fraction after treatment of purified virus with Triton X-100 ( VT-17, VT-24, VT-25, VT-26, VT-27, VT-28, VT-30, VT-31, VT-35, VT-36, VT-37 and VT-38) that precipitated four proteins (150K, 140K, 120K and 51K) when the purified virus was used as antigen ( Table 2) . Four of them (VT-15, VT-25, VT-31 and VT-35) precipitated also a 135K protein when the [35S]methionine_labelled infected cell lysate was used as antigen (Table 2 ; Fig.  3, lane 2) , and also revealed a band of 51K by Western blot analysis (Fig. 4, lane 3) . They precipitated the 150K, 135K, 120K and 51K proteins and a 38K protein of a weak intensity when the [3H]glucosamine-labelled infected cell lysate was used as antigen (Table 2 ; Fig. 5, lane  1) . Thus the 140K protein appeared not to be glycosylated. However, this 140K protein was precipitated by each antibody tested and by control sera from uninfected cattle and disappeared from the immunoprecipitation profile when the envelope extract was used as antigen (Table 2) . Under non-reducing conditions, the 120K and the 51K proteins were not apparent, and a new band of 170K was revealed (Fig. 3) . MAb VT-26 showed the same antigenic specificity as shown by immunoprecipitation and SDS-PAGE analysis but no band was detected by Western blot analysis. The other MAbs of the first group precipitated 135K and 120K (VT-27, VT-28 and VT- [3H]glucosamine-labelled infected cell lysate was used as antigen, but they showed the immunoprecipitation pattern of MAbs of the first group when purified virus was used as antigen (Table  2) . These MAbs did not reveal any band by Western blot analysis.
The second group (group 2) contained 14 MAbs (VT-2, VT-4, VT-6, VT-7, VT-9, VT-11, VT-16, VT-18, VT-19, VT-20, VT-23, VT-29, VT-32 and VT-33) which precipitated the 140K and 120K proteins when purified virus was used as antigen (Table 2 ). This group of MAbs was divided into three subgroups by Western blot analysis. Subgroup 1 (VT-2, VT-4, VT-11, VT-18 and VT-20) revealed a 16.5K protein (Fig. 4, lane 2) , subgroup 2 (VT-6, VT-7 and VT-9) revealed a 120K protein (Fig. 4, lane 1) and subgroup 3 (VT-16, VT-19, VT-23, VT-29, VT-32 and VT-33) did not recognize any protein by Western blotting (Table 2 ). In some gels two proteins of 56K and 30K were present as diffuse bands of low intensity after immunoprecipitation from [35S]methionine-or [3H]glucosamine-labelled infected cell lysate (Table 2 ; Fig. 5, lane 3) . A weak band of 16-5K appeared after immunoprecipitation from [35S]methionine-labelled infected cell lysate by MAbs VT-2 and VT-4 (Table 2 ). There was no difference in the immunoprecipitation patterns of group 2 MAbs obtained under reducing or non-reducing conditions (data not shown).
DISCUSSION
Electrophoresis of BHV-4 virions on SDS-polyacrylamide gels and immunoprecipitation by
MAbs revealed 29 distinct bands. This is in good agreement with studies of other herpesviruses. By using the same technique, 33, 20 and 25 proteins were revealed in HSV (Spear & Roizman, 1972) , in pseudorabies virus (Stevely, 1975) , and in BHV-1 (Misra et al., 1981) respectively. Of the 29 BHV-4 proteins, 10 could be labelled with [3H]glucosamine and are thought to be glycoproteins. All these glycoproteins were specifically solubilized by treatment of the virions with On: Thu, 03 Jan 2019 09:17:03 Triton X-100 and none of them was present in the nucleocapsid fraction, which would suggest that they are associated with the viral envelope. One band (VP7, 140K) showed a higher intensity on the autoradiographs when compared with other proteins and was present only in the nucleocapsid fraction. Therefore this protein must be the major capsid protein. Three nonglycosylated proteins (VP19, VP24 and VP28) were distributed in the envelope and nucleocapsid fractions. Whether these proteins are identical in the two fractions or whether distinct envelope and nucleocapsid proteins comigrate in the gels remains to be ascertained. In this study, a panel of MAbs was selected and characterized with respect to their reactivity with BHV-4 glycoproteins. One group of 17 MAbs precipitated GVP6 (150K), GVP10 (120K) and GVP17 (51K) and a second group of 14 MAbs was specific for a 120K protein (GVP11) which seems to be different from G V P 10. The first group of M A b s was more extensively studied and found to precipitate more than one protein as has been previously observed for MAbs raised against other herpesviruses, i.e. HSV-1 (Zweig et al., 1980) , pseudorabies virus (Hampl et al., 1984) and BHV-1 (van Drunen Little-van den Hurk et al., 1984) . Five MAbs VT°25, The 135K protein disappeared when purified virus was used as antigen; this suggests that it could be a precursor. The 140K protein was precipitated by each MAb and by sera of uninfected cows; this suggests that 140K was non-specifically precipitated. This contamination could be explained by the abundance of the protein or by Protein A having an affinity for this protein.
4~ ~o
Identification of MAbs of group 1, specific for 15OK, 120K and 51K (GVP6, GVPIO, GVP17) and of group 2, specific for 120K
Under non-reducing conditions, the 120K and 51K glycoproteins were no longer apparent, the 150K glycoprotein was still present and a new band of 170K was revealed, indicating that the 51K and the 120K glycoproteins are linked by disulphide bonds to form a 170K glycoprotein and that this complex is bound non-covalently to the 150K protein. As some MAbs of the first group revealed the 51K protein by Western blot analysis and coprecipitated the 135K precursor when cell lysate was used as antigen, 51K must be a cleavage product of 135K. Other MAbs of this group precipitated only the 135K and 120K proteins and hence were directed against an epitope common to the 135K and 120K proteins, suggesting that the 135K protein is also a precursor of the 120K protein.
The second group (group 2) of 14 MAbs precipitated a glycoprotein of 120K (GVP11) which seems to be different from the 120K (GVP10) precipitated by the first group of MAbs. Indeed, the 150K and 51K proteins did not appear on SDS-PAGE gels after immunoprecipitation from [35S]methionine-labelled purified virus and there was no difference in the immunoprecipitation patterns obtained under reducing or non-reducing conditions. By Western blot analysis some of these MAbs detected the 120K protein (VT-6, VT-7 and Vq~-9) and others a 16-5K protein (VT-2, VT-4, . This suggests that the 120K (GVP 1 l) protein is linked to the 16.5K protein detected by Western blotting. The latter protein was only weakly detected by autoradiography after precipitation by VT-2 and VT-4, suggesting that it is poor in methionine. Some MAbs of this group precipitated 56K and 30K proteins which showed a weak intensity on autoradiographs after [35S]methionine and [3H]glucosamine labelling of the infected cell lysate. These proteins could be coprecipitated glycoproteins. However, they were not precipitated when purified virus was used as antigen and they were more likely to be cleavage products or degraded proteins.
Antibodies to virus glycoproteins gave cytoplasmic as well as surface fluorescence. Antibodies raised against the same glycoprotein complex gave both types of fluorescence, showing that the antigen can accumulate both in the cytoplasm and at the cell surface. These antibodies to the virus glycoproteins could be a useful tool for studying their post-synthetic processing.
Of 10 glycoproteins identified by [3H]glucosamine labelling only six were detected after immunoprecipitation by sera of infected cattle (GVP3, GVP6, GVP8, GVP10, GVP11 and GVP17) and only four were identified by MAbs (GPV6, GVP10, GVP11 and GVP17). GVP3 and GVP8 were not detected by MAbs. This could be explained by the procedure used to produce the MAbs, immunization of mice, which is different from a natural infection. The use of immunofluorescence as a screening procedure to select hybridomas could be another explanation of the failure to detect these two glycoproteins. Their epitopes may have been destroyed by acetone fixation, but additional fusions are required to check these possibilities. Four glycoproteins were not detected by sera from infected cows. These glycoproteins may be less immunogenic or not exposed on the surface of the viral envelope.
In summary, 29 structural proteins were identified of which l0 were glycosylated, and our results suggest that GVP6/GVP 10/GVP 17 and GVP11 are two major glycoproteins. The role of individual envelope glycoproteins in neutralization and viral entry is currently under investigation. Panels of antibodies such as those produced here and the identification of individual epitopes on the envelope proteins will enable extensive studies on their immunological and functional importance.
